Myeloma Today Spring 2010 Volume 8 Issue 2

Dear Reader 

  • A Message from the President 

IMF Welcomes Daniel Navid as Senior Global Analyst
Board of Directors

  • The IMF Welcomes Entertainment Industry Executive to Board of Directors; Myeloma Today in conversation with Amy Weiss

Scientific & Clinical

  •  
  • Myeloma Today in Conversation with Dr. Shaji Kumar: Novel Agents for Initial Therapy of Multiple Myeloma: Comparable results with continued initial therapy and delayed transplantation at relapse versus early transplantation

Education and Awareness

  • Spotlight on Advocacy: Important policies and political issues that impact the myeloma community

Patient & Caregiver Experience

  • Myeloma Today in Conversation with Yolanda Brunson-Sarrabo

News & Notes

  • IMF names Prof. Joan Bladé as recipient of the 2010 Robert A. Kyle Lifetime Achievement Award
  • Circulating myeloma cells and autologous stem cell transplantation
  • Phase III trial in smoldering multiple myeloma at high risk of progression

Supportive Care

  •  IMF Hotline Coordinators Answer Your Questions: "Is the use of gadolinium in MRI a necessary part of the imaging test and is it safe?"

Support Groups

  • People Helping People
  • Llamada a la comunidad hispana con el mieloma multiple
  • San Diego, California
  • Montgomery, Alabama
  • Start-up groups seek your support
  • NEW support groups invite YOU to join them
  • IMF welcomes Joanie Borbely as Regional Co-Director of Support Groups SE (South East).
  • 2010 IMF Annual Support Group Leaders’ Retreat
  • How to start a support group and how the IMF can assist you

International Affiliates:

  • Updates from Around the Globe
  • Report from IMF Japan
  • National Myeloma Day in Australia

Member Events

  • Liz Stafford& Greg Kurantowicz Get Married!
  • Misbehave for Myeloma
  • TriBeCans for the Fight Against Myeloma

2010 IMF Calendar of Events
Letters to the IMF

Click here to download Myeloma Today

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.